Call Options Transactions Made in Q3 2023 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q3 2023. The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
50K+ 33.33% |
$95K - $114K
|
200K
$788K
|
|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
11.1KNew |
$21.1K - $25.2K
|
11.1K
$43.7K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-13.3K- 12.15% |
$25.3K - $30.2K
|
96.2K
$379K
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-36.6K- 33.89% |
$69.5K - $83.1K
|
71.4K
$281K
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
CALL |
-83.5K- 30.05% |
$159K - $190K
|
194K
$766K
|